The Farapulse PFA system provides a non-thermal approach for ablating heart tissue related to atrial fibrillation.

Boston Scientific Corporation BSX recently received the Pharmaceuticals and Medical Device Agency’s (“PMDA”) approval in ...

Boston Scientific gets PDMA approval in Japan for FARAPULSE PFA System: Marlborough, Massachusetts Monday, September 30, 2024, 13:00 Hrs [IST] Boston Scientific Corporation, a glo ...

A medical milestone has been achieved in Deep East Texas as the first Left Atrial Appendage Occlusion (LAAO) procedure ...

Boston Scientific Corporation (NYSE: BSX ) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSETM Pulsed Field Ablation (PFA) System. The ...

Magellan Diagnostics is sentenced to pay over $40 million for concealing defects in their lead testing devices.

The Boston Scientific Mobile Learning Lab visited the St. Peter’s Hospital campus on Thursday, September 19, offering clinical staff an opportunity to take part in high-tech, interactive ...

Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The ...

Boston Scientific Corp. (BSX) announced Friday that it has received Pharmaceuticals and Medical Device Agency approval in Japan for ...